TCM
LABD icon

Traynor Capital Management’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Traynor Capital Management’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-151
Closed -$1.29M – 182
2018
Q4 		$1.29M Buy
+151
New +$1.11M 0.54% 37

Other funds holding LABD

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Traynor Capital Management's LABD Position: Q1 2019 in Review

Traynor Capital Management sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2019, closing a stake of 151 shares — an estimated $1.29M sold.

Traynor Capital Management first reported a position in LABD in Q4 2018 and held it in 1 quarter. The position peaked at $1.29M in Q4 2018. 12 funds tracked by Wall St. Rank hold LABD as of Q1 2019.

  • Traynor Capital Management reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2019 after selling out during the quarter.
  • Traynor Capital Management sold 151 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2019, an estimated $1.29M.
  • Traynor Capital Management first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2018 and held it in 1 quarter.
  • Traynor Capital Management's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.29M in Q4 2018.
  • 12 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2019.

Based on Traynor Capital Management's 13F filing for Q1 2019, filed 12 Apr 2019.